Finally, the Rag1−/− mouse model served as a proof-of-concept experiment to analyze the therapeutic effect of FTY720, a sphingosine-1-phosphate receptor modulator, in models of cerebral ischemia [22] and to determine the contribution of lymphocytes to angiotensin II-induced microvascular dysfunction [34]. The gene discussed is RAG1; the disease is brain ischemia.